Álvaro Rodríguez Lescure-rekin lankidetzan egindako argitalpenak (8)

2010

  1. Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

    Breast Cancer Research and Treatment, Vol. 122, Núm. 1, pp. 169-176

2003

  1. High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

    Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 5, Núm. 3, pp. 148-155

  2. High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

    Clinical and Translational Oncology, Vol. 5, Núm. 3, pp. 148-155

1998

  1. Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicin

    Breast Cancer Research and Treatment, Vol. 50, Núm. 2, pp. 167-174

1997

  1. Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.

    Oncology (Williston Park, N.Y.), Vol. 11, Núm. 9 Suppl 10, pp. 83-85

1996

  1. Acute and anticipatory emesis in breast cancer patients

    Supportive Care in Cancer, Vol. 4, Núm. 5, pp. 370-377

1994

  1. Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer

    Journal of Clinical Oncology, Vol. 12, Núm. 5, pp. 986-991

  2. Prednimustine-induced myoclonus-a report of three cases

    Acta Oncologica, Vol. 33, Núm. 1, pp. 81-82